Dyno Therapeutics
PrivateLast Round
Series A
May 6, 2021
Est. Valuation
$539.27M
Total Funding Raised
$109M
Company Overview
Dyno Therapeutics is a biotechnology company that provides advanced technologies for innovative gene therapies through its AI-driven platform, which integrates next-generation DNA synthesis of AAV capsids with high-throughput sequencing and machine learning to facilitate safe and efficient in vivo delivery of novel AAV vectors for medical research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dyno Therapeutics Comparables
Compare Dyno Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Capsida Biotherapeutics | 83% | |
| Shape Therapeutics | 81% | |
| Voyager Therapeutics | 78% | |
Dyno Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 6, 2021 | ||||
| Seed | Nov 1, 2018 |
Key People
Founding team and executive leadership
Dyno Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A |
| GV | Series A |
| Lux Capital | Series A |
| Obvious Ventures | Series A |
| CRV | Series A, Seed |
| Casdin Capital | Series A |
| Polaris Partners | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2026
Open release of curated synthetic domain interfaces dataset.
- Mar 18, 2026
Attended and launched a product at the GTC 2026 conference.
Dyno Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Dyno Therapeutics's valuation, stock price, and market status.